EFPIA Newsletter 14 January 2021

19 Conversations | The EFPIA podcast series     By Johanna Mercier, Gilead   Today we're asking Johanna Mercier, Chief Commercial Officer at Gilead "How is the pharmaceutical industry contributing to the fight against COVID-19?" Read more →

News     14 January 2021 EFPIA response to Inception Impact Assessment on Orphan and Paediatric Regulations EFPIA members are committed to ensuring that unmet needs are addressed and that available treatments reach all European... Read more →         25 December 2020 Joint EU-UK pharmaceutical industry response to Brexit deal The UK and the EU have agreed on a post-Brexit trade deal. Read more →

Blogs     13 January 2021 The IMI Journey of Central Denmark How IMI has enabled the connections in an ecosystem encompassing regional, national and EU actors within collaborative... Read more →

#QuestionsInspireSolutions

	What is the one thing you want people to know about preventing drug shortages? Export restrictions, requisitioning and stockpiling exacerbate shortages and put pressure on a highly orchestrated supply chain designed to function across borders, says Simon White.		How resilient were Europe’s pharmaceutical supply chains before COVID? During the pandemic, the pharmaceutical industry showed the ability of reacting quickly and its resilience built over the years. Hear more from Christopher Schmidt, Senior Director, Head of Supply Network Operations EMEAR (Europe, Middle East, Africa & Russia) at Merck Group.

	What specific challenges are there for vaccine supply chains? Alberto Cifuentes, Director, Customer Service & Strategy Lead EMEA, Pfizer, gives us some examples of internal and external challenges.		What can policymakers do ensure that medicines reach patients in a timely way? Alberto Cifuentes, Director, Customer Service & Strategy Lead EMEA, Pfizer, explains why it is vital that all partners work together.

Events     31 JAN 2021   Enter the EURORDIS Photo Award 2020 Online Award The EURORDIS Photo Award is an opportunity to visually express what it means to live with a rare disease and to share... Learn more →       04 FEB 2021   9th ACCELERATE Paediatric Oncology Conference Virtual event REGISTRATION IS NOW OPEN with specially reduced rates available before the early rate deadline of 4 January 2021. Learn more →

	04 MAR 2021			Value Based Healthcare Conference – Tallinn 2021 Virtual event The conference aims at raising awareness and knowledge among the healthcare community on the value of patient-centered... Learn more →

	15 MAR 2021			DIA Europe 2021 Virtual event Dedicated to Advancing Healthcare Priorities Learn more →

What we are reading mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry 11 January 2021  (Time) Read more → Ten reasons we got Covid-19 vaccines so quickly without 'cutting corners' 26 December 2020  (The Guardian) Read more → Speeding up patient access requires dealing with uncertainty on clinical value first, negotiating... 15 December 2020  (Vintura) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe